Articoli con mandati relativi all'accesso pubblico - Robert LangerUlteriori informazioni
Non disponibili pubblicamente: 35
Controlla
Nanoparticle delivery of cancer drugs
AZ Wang, R Langer, OC Farokhzad
Annual review of medicine 63 (1), 185-198, 2012
Mandati: US National Institutes of Health
Controlla
Bioresponsive materials
Y Lu, AA Aimetti, R Langer, Z Gu
Nature Reviews Materials 2 (1), 1-17, 2016
Mandati: US National Institutes of Health
Controlla
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile
J Hrkach, D Von Hoff, MM Ali, E Andrianova, J Auer, T Campbell, ...
Science translational medicine 4 (128), 128ra39-128ra39, 2012
Mandati: US National Institutes of Health
Controlla
Nanoparticle-based drug delivery systems: a commercial and regulatory outlook as the field matures
H Ragelle, F Danhier, V Préat, R Langer, DG Anderson
Expert opinion on drug delivery 14 (7), 851-864, 2017
Mandati: US National Institutes of Health, National Fund for Scientific Research, Belgium
Controlla
Biocompatibility and drug delivery systems
DS Kohane, R Langer
Chemical Science 1 (4), 441-446, 2010
Mandati: US National Institutes of Health
Controlla
Three-dimensional biomaterials for the study of human pluripotent stem cells
TP Kraehenbuehl, R Langer, LS Ferreira
Nature methods 8 (9), 731-736, 2011
Mandati: Swiss National Science Foundation, US National Institutes of Health
Controlla
Intracellular delivery of core–shell fluorescent silica nanoparticles
JE Fuller, GT Zugates, LS Ferreira, HS Ow, NN Nguyen, UB Wiesner, ...
Biomaterials 29 (10), 1526-1532, 2008
Mandati: US National Institutes of Health
Controlla
Ingestible electronics for diagnostics and therapy
C Steiger, A Abramson, P Nadeau, AP Chandrakasan, R Langer, ...
Nature Reviews Materials 4 (2), 83-98, 2019
Mandati: US National Institutes of Health
Controlla
Stability of proteins and their delivery from biodegradable polymer microspheres
SP Schwendeman, M Cardamone, A Klibanov, R Langer, MR Brandon
Microparticulate systems for the delivery of proteins and vaccines, 1-49, 2020
Mandati: US National Institutes of Health
Controlla
Smart biomaterials: recent advances and future directions
PS Kowalski, C Bhattacharya, S Afewerki, R Langer
ACS biomaterials science & engineering 4 (11), 3809-3817, 2018
Mandati: Juvenile Diabetes Research Foundation
Controlla
Biodegradable xylitol‐based polymers
JP Bruggeman, CJ Bettinger, CLE Nijst, DS Kohane, R Langer
Advanced materials 20 (10), 1922-1927, 2008
Mandati: US National Institutes of Health
Controlla
Glucose-responsive insulin by molecular and physical design
NA Bakh, AB Cortinas, MA Weiss, RS Langer, DG Anderson, Z Gu, ...
Nature chemistry 9 (10), 937-944, 2017
Mandati: Juvenile Diabetes Research Foundation
Controlla
The smartest materials: the future of nanoelectronics in medicine
T Cohen-Karni, R Langer, DS Kohane
ACS nano 6 (8), 6541-6545, 2012
Mandati: US National Institutes of Health
Controlla
Five years of siRNA delivery: spotlight on gold nanoparticles
AKR Lytton‐Jean, R Langer, DG Anderson
Small 7 (14), 1932-1937, 2011
Mandati: US National Institutes of Health
Controlla
Optimizing the delivery of cancer drugs that block angiogenesis
Y Cao, R Langer
Science translational medicine 2 (15), 15ps3-15ps3, 2010
Mandati: US National Institutes of Health, Swedish Research Council
Controlla
Living biomaterials
MW Tibbitt, R Langer
Accounts of chemical research 50 (3), 508-513, 2017
Mandati: US National Institutes of Health
Controlla
Three‐dimensional conductive constructs for nerve regeneration
PM George, R Saigal, MW Lawlor, MJ Moore, DA LaVan, RP Marini, ...
Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2009
Mandati: US National Institutes of Health
Controlla
Heterogeneity in skin treated with low-frequency ultrasound
J Kushner IV, D Blankschtein, R Langer
Journal of pharmaceutical sciences 97 (10), 4119-4128, 2008
Mandati: US National Institutes of Health
Controlla
A methodology for investigating protein adhesion and adsorption to microarrayed combinatorial polymers
M Taylor, AJ Urquhart, DG Anderson, PM Williams, R Langer, ...
Macromolecular Rapid Communications 29 (15), 1298-1302, 2008
Mandati: US National Institutes of Health
Controlla
Rheological blends for drug delivery. I. Characterization in vitro
T Hoare, D Zurakowski, R Langer, DS Kohane
Journal of Biomedical Materials Research Part A: An Official Journal of The …, 2010
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software